A 0 1 0 1 O
prolonged 2 11 2 11 O
history 12 19 12 19 O
of 20 22 20 22 O
cigarette 23 32 23 32 O
smoking 33 40 33 40 O
( 41 42 41 42 O
20 42 44 42 44 O
pk 45 47 45 47 O
/ 47 48 47 48 O
year 48 52 48 52 O
of 53 55 53 55 O
smoking 56 63 56 63 O
within 64 70 64 70 O
the 71 74 71 74 O
past 75 79 75 79 B-upper_bound
2 80 81 80 81 I-upper_bound
years 82 87 82 87 I-upper_bound
) 87 88 87 88 O

Absolute 0 8 89 97 B-clinical_variable
neutrophil 9 19 98 108 I-clinical_variable
count 20 25 109 114 I-clinical_variable
greater 26 33 115 122 O
than 34 38 123 127 O
1000 39 43 128 132 B-lower_bound
/ 43 44 132 133 I-lower_bound
mm(3 44 48 133 137 I-lower_bound
) 48 49 137 138 I-lower_bound
without 50 57 139 146 O
the 58 61 147 150 O
support 62 69 151 158 O
of 70 72 159 161 O
filgrastim 73 83 162 172 B-treatment

Active 0 6 173 179 O
systemic 7 15 180 188 B-chronic_disease
infections 16 26 189 199 I-chronic_disease
, 26 27 199 200 O
( 28 29 201 202 O
e.g. 29 33 202 206 O
: 33 34 206 207 O
requiring 35 44 208 217 O
anti 45 49 218 222 B-treatment
- 49 50 222 223 I-treatment
infective 50 59 223 232 I-treatment
treatment 60 69 233 242 I-treatment
) 69 70 242 243 O
, 70 71 243 244 O
coagulation 72 83 245 256 B-chronic_disease
disorders 84 93 257 266 I-chronic_disease
or 94 96 267 269 O
any 97 100 270 273 O
other 101 106 274 279 O
active 107 113 280 286 O
major 114 119 287 292 O
medical 120 127 293 300 B-chronic_disease
illnesses 128 137 301 310 I-chronic_disease

Age 0 3 311 314 B-age
greater 4 11 315 322 O
than 12 16 323 327 O
or 17 19 328 330 O
equal 20 25 331 336 O
to 26 28 337 339 O
65 29 31 340 342 B-lower_bound
years 32 37 343 348 I-lower_bound
old 38 41 349 352 O

Any 0 3 353 356 O
form 4 8 357 361 O
of 9 11 362 364 O
primary 12 19 365 372 B-chronic_disease
immunodeficiency 20 36 373 389 I-chronic_disease
( 37 38 390 391 O
such 38 42 391 395 O
as 43 45 396 398 O
Severe 46 52 399 405 B-chronic_disease
Combined 53 61 406 414 I-chronic_disease
Immunodeficiency 62 78 415 431 I-chronic_disease
Disease 79 86 432 439 I-chronic_disease
) 86 87 439 440 O

Any 0 3 441 444 O
patient 4 11 445 452 O
known 12 17 453 458 O
to 18 20 459 461 O
have 21 25 462 466 O
an 26 28 467 469 O
LVEF 29 33 470 474 B-clinical_variable
less 34 38 475 479 O
than 39 43 480 484 O
or 44 46 485 487 O
equal 47 52 488 493 O
to 53 55 494 496 O
45 56 58 497 499 B-upper_bound
% 58 59 499 500 I-upper_bound

Clinical 0 8 501 509 O
performance 9 20 510 521 O
status 21 27 522 528 O
of 28 30 529 531 O
ECOG 31 35 532 536 B-clinical_variable
0 36 37 537 538 B-lower_bound
, 37 38 538 539 O
1 39 40 540 541 O
or 41 43 542 544 O
2 44 45 545 546 B-upper_bound

Clinically 0 10 547 557 O
significant 11 22 558 569 O
atrial 23 29 570 576 B-chronic_disease
and 30 33 577 580 O
or 34 36 581 583 O
ventricular 37 48 584 595 B-chronic_disease
arrhythmias 49 60 596 607 I-chronic_disease
including 61 70 608 617 O
but 71 74 618 621 O
not 75 78 622 625 O
limited 79 86 626 633 O
to 87 89 634 636 O
: 89 90 636 637 O
atrial 91 97 638 644 B-chronic_disease
fibrillation 98 110 645 657 I-chronic_disease
, 110 111 657 658 O
ventricular 112 123 659 670 B-chronic_disease
tachycardia 124 135 671 682 I-chronic_disease
, 135 136 682 683 O
second 137 143 684 690 O
or 144 146 691 693 O
third 147 152 694 699 B-chronic_disease
degree 153 159 700 706 I-chronic_disease
heart 160 165 707 712 I-chronic_disease
block 166 171 713 718 I-chronic_disease
or 172 174 719 721 O
history 175 182 722 729 O
of 183 185 730 732 O
ischemic 186 194 733 741 B-chronic_disease
heart 195 200 742 747 I-chronic_disease
disease 201 208 748 755 I-chronic_disease
or 209 211 756 758 O
chest 212 217 759 764 B-chronic_disease
pain 218 222 765 769 I-chronic_disease

Concurrent 0 10 770 780 O
opportunistic 11 24 781 794 B-chronic_disease
infections 25 35 795 805 I-chronic_disease
( 36 37 806 807 O
The 37 40 807 810 O
experimental 41 53 811 823 O
treatment 54 63 824 833 B-treatment
being 64 69 834 839 O
evaluated 70 79 840 849 O
in 80 82 850 852 O
this 83 87 853 857 O
protocol 88 96 858 866 O
depends 97 104 867 874 O
on 105 107 875 877 O
an 108 110 878 880 O
intact 111 117 881 887 O
immune 118 124 888 894 O
system 125 131 895 901 O

Concurrent 0 10 902 912 O
systemic 11 19 913 921 B-treatment
steroid 20 27 922 929 I-treatment
therapy 28 35 930 937 I-treatment

Confirmation 0 12 938 950 O
of 13 15 951 953 O
diagnosis 16 25 954 963 O
of 26 28 964 966 O
metastatic 29 39 967 977 B-cancer
melanoma 40 48 978 986 I-cancer
by 49 51 987 989 O
the 52 55 990 993 O
Laboratory 56 66 994 1004 O
of 67 69 1005 1007 O
Pathology 70 79 1008 1017 O
of 80 82 1018 1020 O
NCI 83 86 1021 1024 O

Documented 0 10 1025 1035 O
FEV1 11 15 1036 1040 B-clinical_variable
less 16 20 1041 1045 O
than 21 25 1046 1050 O
or 26 28 1051 1053 O
equal 29 34 1054 1059 O
to 35 37 1060 1062 O
60 38 40 1063 1065 B-upper_bound
% 40 41 1065 1066 I-upper_bound
predicted 42 51 1067 1076 O
tested 52 58 1077 1083 O
in 59 61 1084 1086 O
patients 62 70 1087 1095 O

Documented 0 10 1096 1106 O
LVEF 11 15 1107 1111 B-clinical_variable
of 16 18 1112 1114 O
less 19 23 1115 1119 O
than 24 28 1120 1124 O
or 29 31 1125 1127 O
equal 32 37 1128 1133 O
to 38 40 1134 1136 O
45 41 43 1137 1139 B-upper_bound
% 43 44 1139 1140 I-upper_bound

Greater 0 7 1141 1148 O
than 8 12 1149 1153 O
or 13 15 1154 1156 O
equal 16 21 1157 1162 O
to 22 24 1163 1165 O
18 25 27 1166 1168 B-lower_bound
years 28 33 1169 1174 I-lower_bound
of 34 36 1175 1177 O
age 37 40 1178 1181 B-age
and 41 44 1182 1185 O
less 45 49 1186 1190 O
than 50 54 1191 1195 O
or 55 57 1196 1198 O
equal 58 63 1199 1204 O
to 64 66 1205 1207 O
70 67 69 1208 1210 B-upper_bound
years 70 75 1211 1216 I-upper_bound
of 76 78 1217 1219 O
age 79 82 1220 1223 O

Hemoglobin 0 10 1224 1234 B-clinical_variable
> 11 12 1235 1236 O
8.0 13 16 1237 1240 B-lower_bound
g 17 18 1241 1242 I-lower_bound
/ 18 19 1242 1243 I-lower_bound
dl 19 21 1243 1245 I-lower_bound

History 0 7 1246 1253 O
of 8 10 1254 1256 O
coronary 11 19 1257 1265 B-treatment
revascularization 20 37 1266 1283 I-treatment
or 38 40 1284 1286 O
ischemic 41 49 1287 1295 B-chronic_disease
symptoms 50 58 1296 1304 I-chronic_disease

History 0 7 1305 1312 O
of 8 10 1313 1315 O
severe 11 17 1316 1322 O
immediate 18 27 1323 1332 O
hypersensitivity 28 44 1333 1349 O
reaction 45 53 1350 1358 O
to 54 56 1359 1361 O
any 57 60 1362 1365 O
of 61 63 1366 1368 O
the 64 67 1369 1372 O
agents 68 74 1373 1379 B-allergy_name
used 75 79 1380 1384 I-allergy_name
in 80 82 1385 1387 I-allergy_name
this 83 87 1388 1392 I-allergy_name
study 88 93 1393 1398 I-allergy_name

Measurable 0 10 1399 1409 O
metastatic 11 21 1410 1420 B-cancer
melanoma 22 30 1421 1429 I-cancer
with 31 35 1430 1434 O
at 36 38 1435 1437 O
least 39 44 1438 1443 O
one 45 48 1444 1447 B-lower_bound
lesion 49 55 1448 1454 O
that 56 60 1455 1459 O
is 61 63 1460 1462 O
resectable 64 74 1463 1473 O
for 75 78 1474 1477 O
TIL 79 82 1478 1481 O
generation 83 93 1482 1492 O
and 94 97 1493 1496 O
at 98 100 1497 1499 O
least 101 106 1500 1505 O
one 107 110 1506 1509 O
other 111 116 1510 1515 O
lesion 117 123 1516 1522 O
that 124 128 1523 1527 O
can 129 132 1528 1531 O
be 133 135 1532 1534 O
measured 136 144 1535 1543 O
by 145 147 1544 1546 O
RECIST 148 154 1547 1553 O
criteria 155 163 1554 1562 O

More 0 4 1563 1567 O
than 5 9 1568 1572 O
four 10 14 1573 1577 B-lower_bound
weeks 15 20 1578 1583 I-lower_bound
must 21 25 1584 1588 O
have 26 30 1589 1593 O
elapsed 31 38 1594 1601 O
since 39 44 1602 1607 O
any 45 48 1608 1611 O
prior 49 54 1612 1617 B-treatment
systemic 55 63 1618 1626 I-treatment
therapy 64 71 1627 1634 I-treatment
at 72 74 1635 1637 O
the 75 78 1638 1641 O
time 79 83 1642 1646 O
the 84 87 1647 1650 O
patient 88 95 1651 1658 O
receives 96 104 1659 1667 O
the 105 108 1668 1671 O
preparative 109 120 1672 1683 B-treatment
regimen 121 128 1684 1691 I-treatment
, 128 129 1691 1692 O
and 130 133 1693 1696 O
patients 134 142 1697 1705 O
toxicities 143 153 1706 1716 O
must 154 158 1717 1721 O
have 159 163 1722 1726 O
recovered 164 173 1727 1736 O
to 174 176 1737 1739 O
a 177 178 1740 1741 O
grade 179 184 1742 1747 B-upper_bound
1 185 186 1748 1749 I-upper_bound
or 187 189 1750 1752 O
less 190 194 1753 1757 O
( 195 196 1758 1759 O
except 196 202 1759 1765 O
for 203 206 1766 1769 O
toxicities 207 217 1770 1780 O
such 218 222 1781 1785 O
as 223 225 1786 1788 O
alopecia 226 234 1789 1797 B-chronic_disease
or 235 237 1798 1800 O
vitiligo 238 246 1801 1809 B-chronic_disease
) 246 247 1809 1810 O
. 247 248 1810 1811 O
Patients 249 257 1812 1820 O
must 258 262 1821 1825 O
have 263 267 1826 1830 O
progressive 268 279 1831 1842 O
disease 280 287 1843 1850 O
after 288 293 1851 1856 O
prior 294 299 1857 1862 B-treatment
treatment 300 309 1863 1872 I-treatment

Patients 0 8 1873 1881 O
may 9 12 1882 1885 O
have 13 17 1886 1890 O
undergone 18 27 1891 1900 O
minor 28 33 1901 1906 B-treatment
surgical 34 42 1907 1915 I-treatment
procedures 43 53 1916 1926 I-treatment
within 54 60 1927 1933 O
the 61 64 1934 1937 O
past 65 69 1938 1942 B-upper_bound
3 70 71 1943 1944 I-upper_bound
weeks 72 77 1945 1950 I-upper_bound
, 77 78 1950 1951 O
as 79 81 1952 1954 O
long 82 86 1955 1959 O
as 87 89 1960 1962 O
all 90 93 1963 1966 O
toxicities 94 104 1967 1977 O
have 105 109 1978 1982 O
recovered 110 119 1983 1992 O
to 120 122 1993 1995 O
grade 123 128 1996 2001 B-upper_bound
1 129 130 2002 2003 I-upper_bound
or 131 133 2004 2006 O
less 134 138 2007 2011 O

Patients 0 8 2012 2020 O
of 9 11 2021 2023 O
both 12 16 2024 2028 O
genders 17 24 2029 2036 O
must 25 29 2037 2041 O
be 30 32 2042 2044 O
willing 33 40 2045 2052 B-contraception_consent
to 41 43 2053 2055 I-contraception_consent
practice 44 52 2056 2064 I-contraception_consent
birth 53 58 2065 2070 I-contraception_consent
control 59 66 2071 2078 I-contraception_consent
from 67 71 2079 2083 O
the 72 75 2084 2087 O
time 76 80 2088 2092 O
of 81 83 2093 2095 O
enrollment 84 94 2096 2106 O
on 95 97 2107 2109 O
this 98 102 2110 2114 O
study 103 108 2115 2120 O
and 109 112 2121 2124 O
for 113 116 2125 2128 O
up 117 119 2129 2131 O
to 120 122 2132 2134 O
four 123 127 2135 2139 B-upper_bound
months 128 134 2140 2146 I-upper_bound
after 135 140 2147 2152 O
treatment 141 150 2153 2162 B-treatment

Patients 0 8 2163 2171 O
who 9 12 2172 2175 O
are 13 16 2176 2179 O
receiving 17 26 2180 2189 O
other 27 32 2190 2195 O
investigational 33 48 2196 2211 B-treatment
agents 49 55 2212 2218 I-treatment

Patients 0 8 2219 2227 O
with 9 13 2228 2232 O
3 14 15 2233 2234 B-upper_bound
or 16 18 2235 2237 O
fewer 19 24 2238 2243 O
brain 25 30 2244 2249 B-cancer
metastases 31 41 2250 2260 I-cancer
that 42 46 2261 2265 O
are 47 50 2266 2269 O
less 51 55 2270 2274 O
than 56 60 2275 2279 O
1 61 62 2280 2281 B-upper_bound
cm 63 65 2282 2284 I-upper_bound
in 66 68 2285 2287 O
diameter 69 77 2288 2296 B-clinical_variable
and 78 81 2297 2300 O
asymptomatic 82 94 2301 2313 O

Platelet 0 8 2314 2322 B-clinical_variable
count 9 14 2323 2328 I-clinical_variable
greater 15 22 2329 2336 O
than 23 27 2337 2341 O
or 28 30 2342 2344 O
equal 31 36 2345 2350 O
to 37 39 2351 2353 O
100,000 40 47 2354 2361 B-lower_bound
/ 47 48 2361 2362 I-lower_bound
mm(3 48 52 2362 2366 I-lower_bound
) 52 53 2366 2367 I-lower_bound

Seronegative 0 12 2368 2380 O
for 13 16 2381 2384 O
HIV 17 20 2385 2388 B-chronic_disease
antibody 21 29 2389 2397 O
. 29 30 2397 2398 O
( 31 32 2399 2400 O
The 32 35 2400 2403 O
experimental 36 48 2404 2416 O
treatment 49 58 2417 2426 B-treatment
being 59 64 2427 2432 O
evaluated 65 74 2433 2442 O
in 75 77 2443 2445 O
this 78 82 2446 2450 O
protocol 83 91 2451 2459 O
depends 92 99 2460 2467 O
on 100 102 2468 2470 O
an 103 105 2471 2473 O
intact 106 112 2474 2480 O
immune 113 119 2481 2487 O
system 120 126 2488 2494 O
. 126 127 2494 2495 O
Patients 128 136 2496 2504 O
who 137 140 2505 2508 O
are 141 144 2509 2512 O
HIV 145 148 2513 2516 B-chronic_disease
seropositive 149 161 2517 2529 I-chronic_disease
can 162 165 2530 2533 O
have 166 170 2534 2538 O
decreased 171 180 2539 2548 O
immune 181 187 2549 2555 O
- 187 188 2555 2556 O
competence 188 198 2556 2566 O
and 199 202 2567 2570 O
thus 203 207 2571 2575 O
are 208 211 2576 2579 O
less 212 216 2580 2584 O
responsive 217 227 2585 2595 O
to 228 230 2596 2598 O
the 231 234 2599 2602 O
experimental 235 247 2603 2615 O
treatment 248 257 2616 2625 O
and 258 261 2626 2629 O
more 262 266 2630 2634 O
susceptible 267 278 2635 2646 O
to 279 281 2647 2649 O
its 282 285 2650 2653 O
toxicities 286 296 2654 2664 O
. 296 297 2664 2665 O
) 297 298 2665 2666 O

Serum 0 5 2667 2672 B-clinical_variable
ALT 6 9 2673 2676 I-clinical_variable
/ 9 10 2676 2677 I-clinical_variable
AST 10 13 2677 2680 I-clinical_variable
less 14 18 2681 2685 O
than 19 23 2686 2690 O
or 24 26 2691 2693 O
equal 27 32 2694 2699 O
to 33 35 2700 2702 O
2.5 36 39 2703 2706 B-upper_bound
times 40 45 2707 2712 I-upper_bound
the 46 49 2713 2716 I-upper_bound
upper 50 55 2717 2722 I-upper_bound
limit 56 61 2723 2728 I-upper_bound
of 62 64 2729 2731 I-upper_bound
normal 65 71 2732 2738 I-upper_bound

Serum 0 5 2739 2744 O
Creatinine 6 16 2745 2755 B-clinical_variable
less 17 21 2756 2760 O
than 22 26 2761 2765 O
or 27 29 2766 2768 O
equal 30 35 2769 2774 O
to 36 38 2775 2777 O
1.6 39 42 2778 2781 B-upper_bound
mg 43 45 2782 2784 I-upper_bound
/ 45 46 2784 2785 I-upper_bound
dl 46 48 2785 2787 I-upper_bound

Symptoms 0 8 2788 2796 O
of 9 11 2797 2799 O
respiratory 12 23 2800 2811 B-chronic_disease
dysfunction 24 35 2812 2823 I-chronic_disease

Total 0 5 2824 2829 B-clinical_variable
bilirubin 6 15 2830 2839 I-clinical_variable
less 16 20 2840 2844 O
than 21 25 2845 2849 O
or 26 28 2850 2852 O
equal 29 34 2853 2858 O
to 35 37 2859 2861 O
1.5 38 41 2862 2865 B-upper_bound
mg 42 44 2866 2868 I-upper_bound
/ 44 45 2868 2869 I-upper_bound
dl 45 47 2869 2871 I-upper_bound
, 47 48 2871 2872 O
except 49 55 2873 2879 O
in 56 58 2880 2882 O
patients 59 67 2883 2891 O
with 68 72 2892 2896 O
Gilbert 73 80 2897 2904 B-chronic_disease
s 81 82 2905 2906 I-chronic_disease
Syndrome 83 91 2907 2915 I-chronic_disease
who 92 95 2916 2919 O
must 96 100 2920 2924 O
have 101 105 2925 2929 O
a 106 107 2930 2931 O
total 108 113 2932 2937 B-clinical_variable
bilirubin 114 123 2938 2947 I-clinical_variable
less 124 128 2948 2952 O
than 129 133 2953 2957 O
3.0 134 137 2958 2961 B-upper_bound
mg 138 140 2962 2964 I-upper_bound
/ 140 141 2964 2965 I-upper_bound
dl 141 143 2965 2967 I-upper_bound

WBC 0 3 2968 2971 B-clinical_variable
greater 4 11 2972 2979 O
than 12 16 2980 2984 O
or 17 19 2985 2987 O
equal 20 25 2988 2993 O
to 26 28 2994 2996 O
3000 29 33 2997 3001 B-lower_bound
/ 33 34 3001 3002 I-lower_bound
mm(3 34 38 3002 3006 I-lower_bound
) 38 39 3006 3007 I-lower_bound

Women 0 5 3008 3013 B-gender
of 6 8 3014 3016 O
child 9 14 3017 3022 O
- 14 15 3022 3023 O
bearing 15 22 3023 3030 O
potential 23 32 3031 3040 O
must 33 37 3041 3045 O
have 38 42 3046 3050 O
a 43 44 3051 3052 O
negative 45 53 3053 3061 B-pregnancy
pregnancy 54 63 3062 3071 I-pregnancy
test 64 68 3072 3076 O
because 69 76 3077 3084 O
of 77 79 3085 3087 O
the 80 83 3088 3091 O
potentially 84 95 3092 3103 O
dangerous 96 105 3104 3113 O
effects 106 113 3114 3121 O
of 114 116 3122 3124 O
the 117 120 3125 3128 O
treatment 121 130 3129 3138 B-treatment
on 131 133 3139 3141 O
the 134 137 3142 3145 O
fetus 138 143 3146 3151 O

Women 0 5 3152 3157 B-gender
of 6 8 3158 3160 O
child 9 14 3161 3166 O
- 14 15 3166 3167 O
bearing 15 22 3167 3174 O
potential 23 32 3175 3184 O
who 33 36 3185 3188 O
are 37 40 3189 3192 O
pregnant 41 49 3193 3201 B-pregnancy
or 50 52 3202 3204 O
breastfeeding 53 66 3205 3218 O
because 67 74 3219 3226 O
of 75 77 3227 3229 O
the 78 81 3230 3233 O
potentially 82 93 3234 3245 O
dangerous 94 103 3246 3255 O
effects 104 111 3256 3263 O
of 112 114 3264 3266 O
the 115 118 3267 3270 O
treatment 119 128 3271 3280 B-treatment
on 129 131 3281 3283 O
the 132 135 3284 3287 O
fetus 136 141 3288 3293 O
or 142 144 3294 3296 O
infant 145 151 3297 3303 O

